Synonyms:temozolomide, 85622-93-1, Methazolastone, Temodar, Temodal, Temozolamide, 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, Sch 52365, CCRG-81045, Temozolomidum [Latin], Temozolodida [Spanish], Temozolomidum, CCRG 81045, NSC 362856, Sch-52365, M&B 39831, M&B-39831, NSC-362856, C6H6N6O2, CCRIS 8996, MB 39831, 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one, M & B 39831, BRN 5547136, M-39831, 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide, 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, NSC362856, 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, CHEMBL810, 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide, MLS002701861, YF1K15M17Y, DTXSID5043714, CHEBI:72564, Mk-7365, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, TMZ, NCGC00167429-01, Temozolodida, 3-methyl-4-oxo-3H,4H-imidazo[4,3-d][1,2,3,5]tetrazine-8-carboxamide, 8-CARBAMOYL-3-METHYLIMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE, DTXCID3023714, 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3-Methyl-4-oxo-3,4-dihydroimidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide., 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide, SMR000466338, Temodal (TN), Temodar (TN), CAS-85622-93-1, Temozolomide, VETRANAL(TM), analytical standard, SR-01000759347, temozolomida, UNII-YF1K15M17Y, Temozolomide (JAN/USAN/INN), Temozolomide [USAN:INN:BAN], 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-as-tetrazine-8-carboxamide, IMIDAZO(5,1-D)-1,2,3,5-TETRAZINE-8-CARBOXAMIDE, 3,4-DIHYDRO-3-METHYL-4-OXO-, MFCD00866492, Temozolomide- Bio-X, TEMOZOLOMIDE [MI], TEMOZOLOMIDE [INN], TEMOZOLOMIDE [JAN], Temodar (TN) (Schering), TEMOZOLOMIDE [USAN], SCHEMBL3739, 4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide, TEMOZOLOMIDE [VANDF], TEMOZOLOMIDE [MART.], MLS000759447, MLS001424028, BIDD:GT0204, TEMOZOLOMIDE [USP-RS], TEMOZOLOMIDE [WHO-DD], GTPL7301, TEMOZOLOMIDE [EMA EPAR], Temozolomide, >=98% (HPLC), HMS2051O12, HMS2090B08, HMS2232N13, HMS3264I14, HMS3269P05, HMS3372K13, HMS3393O12, HMS3413D06, HMS3654N05, HMS3677D06, HMS3713H16, Pharmakon1600-01502289, TEMOZOLOMIDE [ORANGE BOOK], TEMOZOLOMIDE [EP MONOGRAPH], 3-methyl-4-oxo-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, ALBB-021358, BCP03692, TEMOZOLOMIDE [USP MONOGRAPH], Tox21_112433, AC-758, BDBM50034562, DL-190, NSC759883, s1237, STK623541, 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide, AKOS005557098, Tox21_112433_1, CCG-100870, CS-0943, DB00853, KS-1216, NC00120, NSC-759883, Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, NCGC00167429-02, NCGC00167429-04, NCGC00167429-05, BP-25388, BT164447, HY-17364, NCI60_003316, BCP0726000154, Temozolomide 100 microg/mL in Acetonitrile, AM20110227, FT-0630936, FT-0674845, SW197500-4, T2744, D06067, EN300-122324, AB00639915-06, AB00639915-08, AB00639915-09, AB00639915_10, AB00639915_11, A841386, Q425088, Q-201786, SR-01000759347-4, SR-01000759347-5, BRD-K32107296-001-04-5, Z1201620684, 3-methyl-4-oxo-8-imidazo[5,1-d][1,2,3,5]tetrazinecarboxamide, Temozolomide, United States Pharmacopeia (USP) Reference Standard, 3-methyl-4-oxidanylidene-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide, 3-Methyl-8-aminocarbonyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, Imidazo[5,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-, {Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-, Temozolomide, Pharmaceutical Secondary Standard; Certified Reference Material, 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide (Temozolomide), 3-Methyl-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide(Temozolomide)
Pubchem:PUBCHEM:5394
Id:1196ab37-be62-52b7-91d8-67495c08659e
Description:nan
